Publications

The Diagnostic Utility of Neurophysiologic Tests for Early Diagnostic of Transthyretin Familial Amyloid Polyneuropathy

AuthID
P-00Q-WJK

Author(s)

Sousa, AP

Valdrez, K

Cardoso, M

Anselmo, J

Freitas, M

Ferreira, H

Coelho, T

Document Type

Article

Year published

2019

Published

in AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, ISSN: 1350-6129

Volume: 26, Issue: sup1, Pages: 70-70 (1)

Conference

16Th International Symposium on Amyloidosis (Isa), Date: MAR 26-29, 2018, Location: Kumamoto, JAPAN, Sponsors: Pfizer, Alnylam Pharmaceut, Sanofi Genzyme, Prothena, Ionis Pharmaceut, Janssen Pharmaceut Inc, Eidos Therapeut, Takeda Pharmaceut Co Ltd, Nihon Pharmaceut Co Ltd, Sumitomo Dainippon Pharma, GlaxoSmithKline K K, Dojin Mol Technologies Inc, Celgene K K, Roche Diagnost K K, Daiichi Sankyo Co Ltd, Novartis Pharma Co Ltd, Mochida Pharmaceut Co Ltd, Astellas Pharma Inc, Chest M I Inc, Eisai Co Ltd, Otsuka Pharmaceut Co Ltd, Bristol Myers Squibb Co, Fujifilm RI Pharma Co Ltd, Kyowa Hakko Kirin Co Ltd, Eiken Chem Co Ltd, FP Pharmaceut Corp, Bayer Yakuhin Ltd, Japan Blood Prod Org, UCB Japan Co Ltd, Teijin Pharma Ltd, Otsuka Pharmaceut Factory Inc, Cyberdyne Inc, IDS Co Ltd, Boehringer Ingenheim Ltd, AbbVie GK, Sysmex Corp, HouRai Medech Co Ltd, Yamashita Med Instruments Co Ltd, NPO Corp Kibou no Mori

Indexing